LANADELUMAB EFFICACY AFTER SWITCHING FROM PLACEBO: RESULTS FROM THE HELP AND HELP OPEN-LABEL EXTENSION STUDIES

被引：1
|
作者：
Tachdjian, R.
Anderson, J.
Busse, P.
Johnston, D.
Kiani, S.
Nurse, C.
Paes, K.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2018年 / 121卷 / 05期
关键词：
D O I：
10.1016/j.anai.2018.09.119
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P171
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [41] Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective, Randomized, Open-Label Trial
    Niimi, Rui
    Kono, Toshibumi
    Nishihara, Atsushi
    Hasegawa, Masahiro
    Kono, Toshihiko
    Sudo, Akihiro
    JBMR PLUS, 2018, 2 (05) : 289 - 294
  • [42] Increased Response to Higher Dose Lanadelumab in Hereditary Angioedema Patients: Exploratory Findings From the HELP and HELP OLE Studies
    Jacobs, Joshua S.
    Bernstein, Jonathan
    Davis-Lorton, Mark
    Li, H. Henry
    Soteres, Daniel F.
    Nurse, Christina
    Paes, Kim
    Sexton, Daniel J.
    Longhurst, Hilary
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB39 - AB39
  • [43] Lanadelumab for prevention of attacks in hereditary angioedema: results from the Phase 3 HELP Study
    Banerji, A.
    Riedl, M. A.
    Bernstein, J. A.
    Cicardi, M.
    Longhurst, H. J.
    Zuraw, B. L.
    Bruelle, J.
    Maurer, M.
    SWISS MEDICAL WEEKLY, 2018, 148 : 28S - 29S
  • [44] Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study
    Percy, Alan K.
    Neul, Jeffrey L.
    Benke, Timothy A.
    Berry-Kravis, Elizabeth M.
    Glaze, Daniel G.
    Marsh, Eric D.
    An, Di
    Bishop, Kathie M.
    Youakim, James M.
    MED, 2024, 5 (09): : 1178 - 1189.e3
  • [45] Initial PrEP product choice: results from the HPTN 084 open-label extension
    Delany-Moretlwe, S.
    Hanscom, B.
    Angira, F.
    Dadabhai, S.
    Gadama, D.
    Mirembe, B.
    Bhondai, M.
    Innes, S.
    Kalonji, D.
    Makhema, J.
    Mandima, P.
    Marais, A.
    Mpendo, J.
    Mukwekwerere, P.
    Mgodi, N.
    Naidoo, V.
    Ntege, P. Nahirya
    Nuwagaba-Biribonwoha, H.
    Roos, E.
    Singh, N.
    Siziba, B.
    Spooner, E.
    Farrior, J.
    Rose, S.
    Piwowar-Manning, E.
    Burton, M.
    Soto-Torres, L.
    Rooney, J.
    Rinehart, A.
    Cohen, M.
    Hosseinipour, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
  • [46] Efficacy of satralizumab in neuromyelitis optica spectrum disorder (nmosd): results from open-label extension periods of sakurasky and sakurastar
    Greenberg, B.
    Bennett, J.
    De Seze, J.
    Kleiter, I.
    Szczechowski, L.
    Yamamura, T.
    Fox, E.
    Weinshenker, B.
    Von Buedingen, H. C.
    Stokmaier, D.
    Klingelschmitt, G.
    Weber, K.
    Costantino, C.
    Traboulsee, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 457 - 457
  • [47] Bimekizumab efficacy and safety up to two years in patients with moderate to severe plaque psoriasis switching from ustekinumab: Results from the interim BE BRIGHT open-label extension trial
    Leonardi, Craig
    Sator, Paul
    Morita, Akimichi
    Kokolakis, Georgios
    Blauvelt, Andrew
    Warren, Richard
    De Cuyper, Dirk
    Madden, Cynthia
    Vanvoorden, Veerle
    Wang, Maggie
    Foley, Peter
    Papp, Kim
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 13 - 14
  • [48] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06) : 950 - 959
  • [49] Clinical Efficacy and Safety of Icatibant: Results from the Controlled and Open-Label Extension Phases of the FAST-1 Trial
    Banerji, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB166 - AB166
  • [50] EFFICACY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Delbello, Melissa P.
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10) : S231 - S231
12345